Cambridge Investment Research Advisors Inc. boosted its position in shares of Exelon Corporation (NASDAQ:EXC - Free Report) by 6.2% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 158,825 shares of the company's stock after buying an additional 9,236 shares during the period. Cambridge Investment Research Advisors Inc.'s holdings in Exelon were worth $7,319,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in Exelon by 2.5% during the 4th quarter. Vanguard Group Inc. now owns 127,335,351 shares of the company's stock worth $4,792,903,000 after purchasing an additional 3,064,673 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of Exelon by 37.2% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 27,618,055 shares of the company's stock worth $1,039,545,000 after buying an additional 7,483,873 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Exelon by 1.4% during the fourth quarter. Geode Capital Management LLC now owns 26,314,296 shares of the company's stock worth $988,080,000 after buying an additional 368,505 shares in the last quarter. Lazard Asset Management LLC lifted its stake in shares of Exelon by 2.7% in the 4th quarter. Lazard Asset Management LLC now owns 24,662,037 shares of the company's stock valued at $928,277,000 after acquiring an additional 653,627 shares during the last quarter. Finally, FMR LLC lifted its stake in shares of Exelon by 46.9% in the 4th quarter. FMR LLC now owns 17,306,652 shares of the company's stock valued at $651,422,000 after acquiring an additional 5,524,103 shares during the last quarter. 80.92% of the stock is owned by institutional investors.
Exelon Trading Up 0.9%
Shares of NASDAQ:EXC traded up $0.40 during trading on Friday, reaching $42.91. The stock had a trading volume of 7,322,596 shares, compared to its average volume of 7,168,525. The stock has a market cap of $43.32 billion, a price-to-earnings ratio of 15.95, a P/E/G ratio of 2.44 and a beta of 0.39. The company has a debt-to-equity ratio of 1.66, a quick ratio of 0.98 and a current ratio of 1.09. Exelon Corporation has a 52 week low of $34.01 and a 52 week high of $48.11. The firm's fifty day moving average is $44.22 and its 200 day moving average is $42.46.
Exelon (NASDAQ:EXC - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $0.92 earnings per share for the quarter, topping analysts' consensus estimates of $0.86 by $0.06. The firm had revenue of $6.71 billion during the quarter, compared to the consensus estimate of $6.30 billion. Exelon had a return on equity of 10.29% and a net margin of 11.44%. The business's revenue was up 11.1% compared to the same quarter last year. During the same period last year, the business posted $0.68 EPS. As a group, equities analysts forecast that Exelon Corporation will post 2.64 EPS for the current fiscal year.
Exelon Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Monday, May 12th were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 3.73%. The ex-dividend date was Monday, May 12th. Exelon's payout ratio is 59.48%.
Wall Street Analyst Weigh In
EXC has been the subject of a number of recent research reports. Wells Fargo & Company upped their target price on Exelon from $46.00 to $50.00 and gave the stock an "equal weight" rating in a report on Friday, May 2nd. Evercore ISI boosted their price target on Exelon from $48.00 to $51.00 and gave the stock an "in-line" rating in a report on Friday, May 2nd. UBS Group reiterated a "neutral" rating and issued a $48.00 price objective (up previously from $46.00) on shares of Exelon in a report on Monday, June 2nd. BMO Capital Markets lifted their target price on shares of Exelon from $46.00 to $50.00 and gave the stock an "outperform" rating in a research report on Monday, April 28th. Finally, Guggenheim boosted their target price on shares of Exelon from $47.00 to $50.00 and gave the stock a "buy" rating in a report on Friday, May 2nd. One analyst has rated the stock with a sell rating, five have given a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $47.40.
View Our Latest Stock Report on EXC
Exelon Profile
(
Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Further Reading

Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.